Indapamide and Hyperbilirubinaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hyperbilirubinaemia aggravated is reported as a side effect among people who take Indapamide (indapamide), especially for people who are female, 60+ old, also take Lactulose, and have Anaemia.

The phase IV clinical study analyzes which people have Hyperbilirubinaemia aggravated when taking Indapamide. It is created by eHealthMe based on reports of 21,640 people who have side effects when taking Indapamide from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

What is Hyperbilirubinaemia aggravated?

Hyperbilirubinaemia aggravated (excess of bilirubin in the blood) is found to be associated with 811 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperbilirubinaemia aggravated.

On Jul, 05, 2026

21,640 people reported to have side effects when taking Indapamide.
Among them, 11 people (0.05%) have Hyperbilirubinaemia aggravated.

Could Indapamide cause Hyperbilirubinaemia aggravated?

Among these 11 people:

What is the gender of people who have Hyperbilirubinaemia aggravated when taking Indapamide? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Hyperbilirubinaemia aggravated when taking Indapamide? *

What are other drugs people take besides Indapamide? *

What are other side effects people have besides Hyperbilirubinaemia aggravated? *

Fever: 4 people, 36.36%
Cough: 3 people, 27.27%
Fatigue (feeling of tiredness): 3 people, 27.27%
Diarrhea: 3 people, 27.27%
Blood Urea Increased: 3 people, 27.27%
White Blood Cell Count Increased: 2 people, 18.18%
Bilirubin Conjugated Increased: 2 people, 18.18%
Bk Virus Infection: 2 people, 18.18%
Oedema Peripheral (superficial swelling): 2 people, 18.18%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 2 people, 18.18%

What are the existing conditions these people have? *

Urination - Excessive Volume: 2 people, 18.18%
Red Blood Cell Count Decreased: 2 people, 18.18%
Lipids Decreased (less lipid in body): 2 people, 18.18%
Incision Site Pain: 2 people, 18.18%
Diarrhea: 2 people, 18.18%
Constipation: 2 people, 18.18%
Anaemia (lack of blood): 2 people, 18.18%
Thyroid Diseases: 1 person, 9.09%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 9.09%
Parkinson's Disease: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and have Hyperbilirubinaemia aggravated?

- Check whether Hyperbilirubinaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indapamide:

Indapamide (22,152 reports)

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperbilirubinaemia aggravated:

Hyperbilirubinaemia aggravated (811 drugs)

Browse all the conditions that are associated with Hyperbilirubinaemia aggravated:

Hyperbilirubinaemia aggravated (377 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indapamide (the active ingredients of Indapamide) and Indapamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.